Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-12

Clinical Trial Update: Autologous Human Schwann Cells in Peripheral Nerve Repair [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous Schwann cells for peripheral nerve repair has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous Human Schwann Cells (Schwann cells)

Snippet

Sponsor: W. Dalton Dietrich | Conditions: Peripheral Nerve Injuries | Phase 1 | Status: COMPLETED